CDC Measles Vaccination Rule Has Left Millions of Vaccinated Americans Without Protection

Lots of babies get measles in Africa and India, and it is a significant cause of death there. A great deal of work has gone into developing measles vaccines that can be given to children at younger and younger ages, especially in . . . Continue reading →

Anthrax Vaccine: history, excessive stockpile & the human and Financial Costs

meryl_nass.jpg

Anthrax Vaccine:  Its checkered history, excessive stockpile and the human and financial costs By Meryl Nass, MD* The current vaccine (Biothrax, manufactured by Emergent Biosolutions or EBS) has never been proved effective in humans. One human trial took place in the 1950s . . . Continue reading →

California Bidding War: Psychiatrist Paid $822,000_Bloomberg

money_down_toilet.jpg

Bloomberg News conducted a data review of payroll records for 1.4 million public employees of the 12 largest states. The findings show that public employees in California earn far higher salaries than in other states, from prison operations to health care, base . . . Continue reading →

Flu Vaccines Are a Waste of Money

flu_jab_next_exit.jpg

Respected international scientists who examined the evidence, concluded that annual influenza campaigns are likely an utter waste of time and money."  But  officials at the US Centers for Disease Control disregard science and accept commercial propaganda as their guide for setting public health policy.

Continue reading →

America’s Healthcare Crisis–Part II–What Do We Get for $$$ ?

burger_pills.jpg

Part II.  What Do We Get for All That Money?  A preventable epidemic of injury and death from prescription drugs; FDA’s contribution to the epidemic;  Big Pharma’s business model: manufactured myths, propaganda and a hidden agenda;

Continue reading →

How FDA Facilitated the Cost of a Drug to Skyrocket

The FDA granted market exclusivity to KV for an old drug that had been available from special pharmacies that custom-compound treatments not approved by the FDA, for $20 a shot. By granting KV market exclusivity, women could no longer obtain the drug, Makena, at a reasonable price– KV set the price at $1,500 a shot. Continue reading →